StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

iBio's profit margin for the twelve months ending Sep 30, 2026 was -3244.2%. For fiscal 2026 it was -33044.0%, against -4594.3% the year before. The highest annual figure on record is -357.9% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 2026-33044.0%−28449.8
FY2025Jun 30, 2025-4594.3%+6475.5
FY2024Jun 30, 2024-11069.8%−8399.8
FY2022Jun 30, 2022-2670.0%−1691.2
FY2021Jun 30, 2021-978.8%+24.8
FY2020Jun 30, 2020-1003.6%−131.8
FY2019Jun 30, 2019-871.8%+2755.4
FY2018Jun 30, 2018-3627.3%+61.1
FY2017Jun 30, 2017-3688.3%−2658.4
FY2016Jun 30, 2016-1030.0%−672.0
FY2015Jun 30, 2015-357.9%+1430.4
FY2014Jun 30, 2014-1788.3%−1172.8
FY2013Jun 30, 2013-615.5%−171.0
FY2012Jun 30, 2012-444.5%+1890.2
FY2011Jun 30, 2011-2334.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 2026-702.4%+3742.2
Q1 FY2026CQ3 2025Sep 30, 2025-5720.0%+5772.0
Q4 FY2025CQ2 2025Jun 30, 2025-2581.5%−1893.2
Q2 FY2025CQ4 2024Dec 31, 2024-2182.0%−2205.6
Q4 FY2024CQ2 2024Jun 30, 2024-4444.6%−3443.1
Q1 FY2024CQ3 2023Sep 30, 2023-11492.0%−10339.0
Q3 FY2022CQ1 2022Mar 31, 2022-688.3%+1149.0
Q4 FY2021CQ2 2021Jun 30, 202123.6%+339.5
Q3 FY2021CQ1 2021Mar 31, 2021-1001.4%+3869.4
Q2 FY2021CQ4 2020Dec 31, 2020-1153.0%+45.0
Q1 FY2021CQ3 2020Sep 30, 2020-1837.3%+2295.1
Q4 FY2020CQ2 2020Jun 30, 2020-315.9%+250.5
Q3 FY2020CQ1 2020Mar 31, 2020-4870.8%−4069.5
Q2 FY2020CQ4 2019Dec 31, 2019-1198.1%−511.6
Q1 FY2020CQ3 2019Sep 30, 2019-4132.4%+5640.9
Q4 FY2019CQ2 2019Jun 30, 2019-566.4%+4288.5
Q3 FY2019CQ1 2019Mar 31, 2019-801.3%+4278.2
Q2 FY2019CQ4 2018Dec 31, 2018-686.5%+1861.9
Q1 FY2019CQ3 2018Sep 30, 2018-9773.3%−6637.3
Q4 FY2018CQ2 2018Jun 30, 2018-4854.9%−1910.0
Q3 FY2018CQ1 2018Mar 31, 2018-5079.5%+5496.2
Q2 FY2018CQ4 2017Dec 31, 2017-2548.4%+1757.0
Q1 FY2018CQ3 2017Sep 30, 2017-3136.1%−868.7
Q4 FY2017CQ2 2017Jun 30, 2017-2944.9%–
Q3 FY2017CQ1 2017Mar 31, 2017-10575.7%–
Q2 FY2017CQ4 2016Dec 31, 2016-4305.3%–
Q1 FY2017CQ3 2016Sep 30, 2016-2267.4%–

More iBio figures

See a number that looks wrong?